VOR

Vor Biopharma Inc.

Healthcare · Biotechnology

$147.32 sample

+2.35 (+1.62%) 1D

Market cap

$686.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-08

Alerts

8

Price$147.32 +4.78% 3M daily closessample

152.02140.47

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08SEC10-Q filed
Sep 29INSInsider buy: 10% owner
Sep 22SEC10-Q filed
Sep 15SEC8-K filed: material event
Sep 10SECForm 144 filed
Sep 02SECDEF 14A filed
Aug 27SEC8-K filed: material event
Aug 24INSInsider sell: General Counsel

Sign up to see the real VOR record →

Company facts

SEC EDGAR registration

Name: Vor Biopharma Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in VOR

sample

Insiders: 13 insider transactions over 90 days, net selling, $61.1M
Congress: No member trades over 90 days
Institutions · 13F: 24 funds hold $7.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.7B +10.6% y/y

Q4 2024Q3 2026

Inventory$12.1B +16.2% y/y

Q4 2024Q3 2026

Accounts receivable$8.6B +7.1% y/y

Q4 2024Q3 2026

Total debt$23.8B +9.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $667.1B -2.1% 3M
Sample peer B: $471.1B -12.9% 3M
Sample peer C: $571.6B +0.6% 3M
Sample peer D: $246.4B +9.6% 3M
Sample peer E: $616.0B +2.7% 3M